Published in Epidemiol Infect on March 01, 1998
Molecular and comparative analysis of Salmonella enterica Senftenberg from humans and animals using PFGE, MLST and NARMS. BMC Microbiol (2011) 0.97
Heterogeneity of persistence of Salmonella enterica serotype Senftenberg strains could explain the emergence of this serotype in poultry flocks. PLoS One (2012) 0.94
Publication bias in foodborne outbreaks of infectious intestinal disease and its implications for evidence-based food policy. England and Wales 1992-2003. Epidemiol Infect (2006) 0.90
Extremely drug-resistant Salmonella enterica serovar Senftenberg infections in patients in Zambia. J Clin Microbiol (2012) 0.86
Mechanisms of survival, responses and sources of Salmonella in low-moisture environments. Front Microbiol (2013) 0.84
ProP is required for the survival of desiccated Salmonella enterica serovar typhimurium cells on a stainless steel surface. Appl Environ Microbiol (2013) 0.82
Salmonellae in food stuffs of plant origin and their implications on human health. Eur J Clin Microbiol Infect Dis (2010) 0.79
Characterization and Evaluation of a Salmonella enterica Serotype Senftenberg Mutant Created by Deletion of Virulence-Related Genes for Use as a Live Attenuated Vaccine. Clin Vaccine Immunol (2016) 0.78
Genomic and Phenotypic Analyses Reveal the Emergence of an Atypical Salmonella enterica Serovar Senftenberg Variant in China. J Clin Microbiol (2016) 0.77
Application of a Rapid Knowledge Synthesis and Transfer Approach To Assess the Microbial Safety of Low-Moisture Foods. J Food Prot (2015) 0.75
Using patient identifiable data without consent. Obtaining individual consent may hinder studies. BMJ (2001) 0.75
Homologous prime-boost immunization with live attenuated Salmonella enterica serovar Senftenberg and its preventive efficacy against experimental challenge with various strains of S. Senftenberg. BMC Vet Res (2017) 0.75
A gene expression map for Caenorhabditis elegans. Science (2001) 9.74
Bacteriophage-typing designations of Salmonella typhimurium. J Hyg (Lond) (1977) 8.59
An outbreak of meningococcal disease in Gloucestershire. Lancet (1986) 6.38
A monoclonal antibody discriminating between subsets of T and B cells. J Immunol (1981) 6.15
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J (2001) 5.94
Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput (2000) 5.83
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76
Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East. J Hyg (Lond) (1977) 4.46
Clonal lines of Salmonella enterica serotype Enteritidis documented by IS200-, ribo-, pulsed-field gel electrophoresis and RFLP typing. J Med Microbiol (1994) 4.43
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect (1987) 4.40
Fundamental elements of the quality of care: a simple framework. Stud Fam Plann (1990) 4.30
Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet (1998) 4.11
Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis (1997) 3.91
Epidemic in cattle and humans of Salmonella typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet Rec (1994) 3.91
Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet (1999) 3.78
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
Ciprofloxacin-resistant Salmonella typhimurium DT104. Vet Rec (1998) 3.61
Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain. J Hyg (Lond) (1986) 3.60
Ciprofloxacin and typhoid fever. Lancet (1992) 3.59
The causes of unmet need for contraception and the social content of services. Stud Fam Plann (1995) 3.48
Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis (2001) 3.35
Application of pulsed-field gel electrophoresis to an international outbreak of Salmonella agona. Emerg Infect Dis (1996) 3.22
Treatment of multiresistant typhoid fever. Lancet (1991) 3.18
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104. Microb Drug Resist (1998) 2.99
Spread of multiresistant strains of Salmonella typhimurium phage types 204 and 193 in Britain. Br Med J (1978) 2.71
Diabetic clinic in a general practice. Br Med J (1971) 2.71
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet (1996) 2.58
Subdivision of Salmonella enteritidis PT 4 by pulsed-field gel electrophoresis: potential for epidemiological surveillance. FEMS Microbiol Lett (1994) 2.44
Unilateral multicystic dysplastic kidney: the case for nephrectomy. Arch Dis Child (1997) 2.35
The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis. Immunogenetics (1991) 2.29
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Chronic pain and quality of life following open inguinal hernia repair. Br J Surg (2001) 2.21
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Subdivision of Salmonella enteritidis phage types by plasmid profile typing. Epidemiol Infect (1989) 2.15
Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev (2007) 2.11
Acquisition of a drug resistance plasmid converts Salmonella enteritidis phage type 4 to phage type 24. Epidemiol Infect (1989) 2.11
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis (2008) 2.06
Ventilatory responses after major surgery and high dependency care. Br J Anaesth (2012) 2.05
Correlation of phaga type, biotype and source in strains of Salmonella typhimurium. J Hyg (Lond) (1978) 2.05
A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Commun Dis Rep CDR Rev (1994) 2.04
Influenza A and meningococcal disease. Lancet (1991) 2.00
bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother (2005) 1.99
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis (2010) 1.98
Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996. Microb Drug Resist (1997) 1.96
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89
Molecular fingerprinting defines a strain of Salmonella enterica serotype Anatum responsible for an international outbreak associated with formula-dried milk. Epidemiol Infect (1998) 1.87
Genotypes and phylogenetic relationships of Salmonella typhimurium are defined by molecular fingerprinting of IS200 and 16S rrn loci. J Gen Microbiol (1993) 1.82
The Salm-gene project - a European collaboration for DNA fingerprinting for food-related salmonellosis. Euro Surveill (2003) 1.81
Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis (1999) 1.81
Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J Clin Microbiol (2001) 1.80
Molecular fingerprinting of multidrug-resistant Salmonella enterica serotype Typhi. Emerg Infect Dis (1998) 1.79
Change of host range in a resistance factor. Genet Res (1970) 1.77
Multiresistant Salmonella typhimurium DT104 in cats: a public health risk. Lancet (1996) 1.75
Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol (2001) 1.75
Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992-5. Epidemiol Infect (1998) 1.74
High-level resistance to ciprofloxacin in Escherichia coli. Lancet (1997) 1.72
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Characterization of resistance plasmids and carried phages in an epidemic clone of multi-resistant Salmonella typhimurium in India. J Hyg (Lond) (1982) 1.69
Multiple drug resistance in salmonellae in England and Wales: a comparison between 1981 and 1988. J Clin Pathol (1990) 1.69
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing. Am J Trop Med Hyg (1986) 1.68
Death following gallbladder surgery. An enquiry into the cause. J R Coll Surg Edinb (1967) 1.67
Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa. Lancet (1981) 1.65
Evolutionary lines among Salmonella enteritidis phage types are identified by insertion sequence IS200 distribution. FEMS Microbiol Lett (1991) 1.64
The emergence and spread of antibiotic resistance in food-borne bacteria. Int J Food Microbiol (2000) 1.64
Genotypic characterization of Salmonella enteritidis phage types by plasmid analysis, ribotyping, and pulsed-field gel electrophoresis. J Clin Microbiol (1998) 1.64
Epidemic spread of Salmonella hadar in England and Wales. Br Med J (1980) 1.63
Peptic ulcer surgery: selection for operation by 'earning'. Gut (1969) 1.63
International adoption of institutionally reared children: research and policy. Dev Psychopathol (2000) 1.62
Community immunization programme in response to an outbreak of invasive Neisseria meningitidis serogroup C infection in the Trent region of England 1995-1996. J Public Health Med (1997) 1.62
Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect (1994) 1.62
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol (1998) 1.60
Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer (2005) 1.60
Mutants of Escherichia coli with altered surface properties which are refractory to colicin E2, sensitive to ultraviolet light and which can also show recombination deficiency, abortive growth of bacteriophage lambda and filament formation. J Gen Microbiol (1970) 1.57
Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med (1976) 1.57
Increasing incidence of resistance to gentamicin and related aminoglycosides in Salmonella typhimurium phage type 204c in England, Wales and Scotland. Vet Rec (1985) 1.56
Multicystic renal dysplasia diagnosed in the antenatal period: a note of caution. Br J Urol (1995) 1.56
Epidermic spread of a chloramphenicol-resistant strain of Salmonella typhimurium phage type 204 in bovine animals in Britain. Vet Rec (1978) 1.56
Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med (1988) 1.55
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53
Bacteriophage restriction in Salmonella typhimurium by R factors and transfer factors. J Hyg (Lond) (1973) 1.52
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52